Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Gs21p the use of adjuvant therapies in colorectal cancer at a regional centre.

Gs21p the use of adjuvant therapies in colorectal cancer at a regional centre. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Gs21p the use of adjuvant therapies in colorectal cancer at a regional centre. Abstract Text:

    d morrisseyD Morrissey,s m yangS M Yang,r franzR Franz,

    Purpose The use of adjuvant therapies in colorectal carcinoma is becoming more common. However, it can be logistically difficult for patients of regional hospitals to have access to such treatments. Our aim was to document the proportion of regional patients with colorectal cancer who received chemotherapy and/or radiotherapy. Method An audit of all patients treated for colorectal cancer at Toowoomba Base Hospital between 1 January 1990 and 1 April 2006 was undertaken. Chemotherapy use, radiotherapy use, anatomical location and histological grade of the cancers were examined. Findings Of the 225 patients who had surgery for Dukes B colonic carcinomas, 22.7% were given chemotherapy. This rate increased to 59.6% for Dukes C colon cancers. 141 rectal cancers were curatively excised during the prescribed period. 39 of these patients received radiotherapy (27.7%). Of these, only 2 (5.13%) had pre-operative radiotherapy. 19 patients had rectal cancers which were considered non resectable and of these, 5 (26.3%) were treated with radiotherapy. Conclusion Despite the paucity of high level evidence showing a benefit in using adjuvant therapy in node negative colon cancers, a relatively large proportion of our regional patients with Dukes B adenocarcinomas were given chemotherapy. The rate of such therapy for Dukes C cancers was comparable to other studies. Fewer than expected patients with rectal adenocarcinomas had radiotherapy. Of those who did receive this, only a very small proportion received pre-operative radiotherapy. It may be that the lower than expected rates of radiotherapy were due to this service being located about 130 km from Toowoomba Hospital.

    Gs21p the use of adjuvant therapies in colorectal cancer at a regional centre. Publishing Authors By Initials

    d morrisseyD Morrissey,sm yangSM Yang,r franzR Franz,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Gs21p the use of adjuvant therapies in colorectal cancer at a regional centre. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: ANZ journal of surgery

    VOLUME: 77 Suppl 1

    Page Numbers: A30

    Journal Abbreviation:

    ISSN: 1445-1433

    DAY: 10

    MONTH: May

    YEAR: 2007

    Gs21p the use of adjuvant therapies in colorectal cancer at a regional centre. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101086634

    Gs21p the use of adjuvant therapies in colorectal cancer at a regional centre. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Gs21p the use of adjuvant therapies in colorectal cancer at a regional centre. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Gs21p the use of adjuvant therapies in colorectal cancer at a regional centre.

    AFFILIATION: Toowoomba Base Hospital, Queensland, Australia.

    Country: Australia

    Australia Research PublicationAustralia Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: ANZ J Surg

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Gs21p the use of adjuvant therapies in colorectal cancer at a regional centre Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News